Cantor Fitzgerald Estimates VKTX FY2026 Earnings
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Viking Therapeutics in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse expects that the biotechnology company will post earnings per share of ($4.01) for the year. Cantor […]
